Home  /  Resource Library  /  Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia

Study examined the prognostic role of CD4 T-cell depletion after treatment with immunochemotherapy in CLL.